Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

Summary

The goal of this pilot clinical trial is to determine feasibility and explore whether financial incentives paid to primary care patients for completing colorectal cancer screening increase completion of colorectal cancer screening. The main questions it aims to answer are:

* Do patient financial incentives for completing colorectal cancer screening increase screening completion?
* Does a patient financial incentive for colorectal cancer screening offered alongside patient financial incentives for COVID-19 and flu shots increase completion of those shots?

Participants who are due for colorectal cancer screening will receive telephone outreach from primary care staff who will offer a stool-based colorectal cancer screening. Participants will be randomly assigned to either Group 1 or Group 2. Group 1 participants will be offered financial incentives for completing COVID-19 and flu shots within 2 months of enrollment. Group 2 participants will be offered financial incentives for completing a COVID-19 shot, a flu shot, and colorectal cancer screening within 2 months of enrollment.

Researchers will compare to see if completion of a COVID-19 shot, a flu shot, and colorectal cancer screening is different between the two groups.

Conditions

• Health Behavior
• Colorectal Cancer
• Influenza
• COVID-19
• Vaccine Hesitancy
• Vaccine-Preventable Diseases
• Healthcare Patient Acceptance

Interventions

BEHAVIORAL

Financial incentive for colorectal cancer screening

$50 incentive paid to participant for completion of colorectal cancer screening within 2 months of enrollment

BEHAVIORAL

Financial incentive for flu shot

$50 incentive paid to participant for completion of flu shot within 2 months of enrollment

BEHAVIORAL

Financial incentive for COVID-19 shot

$50 incentive paid to participant for completion of COVID-19 shot within 2 months of enrollment

Sponsors & Collaborators

• National Heart, Lung, and Blood Institute (NHLBI)

  collaborator NIH

• Tulane University

  lead OTHER

Principal Investigators

• Marie A Krousel-Wood, MD, MSPH · Tulane University

Study Design

Allocation

RANDOMIZED

Purpose

SCREENING

Masking

DOUBLE

Model

PARALLEL

Eligibility

Min Age

45 Years

Max Age

75 Years

Sex

ALL

Healthy Volunteers

Yes

Timeline & Regulatory

Start

2023-11-11

Primary Completion

2024-03-25

Completion

2024-03-25

Countries

• United States

Study Locations